Associate Director, Product Management
BIOGRAPHY
APR 07, 2022 2:00 PM PDT
Genexus System virtual demo with live Q&A
Presented at:
OncomineWorld 2022: A Virtual NGS Education Meeting
Speaker
Abstract
Biomarker testing is an integral part of personalized genome medicine medicine. Number of actionable biomarkers for solid tumours is rapidly expanding. Targeted NGS is a new gold standard, replacing single analyte technologies for identification of DNA sequence variants and fusion transcripts associated with sensitivity to targeted therapies. Oncomine Precision Assay on the Ion Torrent Genexus System is an automated platform for rapid detection of DNA hospot variants and targeted fusions. This presentation will describe our laboratory experience with validation and implementation of the Oncomine Precision Assay for solid tumour testing, focusing on non-small cell lung cancer.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...